ALTERITY THERAPEUTICS-ADR
ATHE · NASDAQ
更新于 2026-10-14 09:20:46
$2.85-2.73%
- 今日最高
- $2.94
- 今日最低
- $2.80
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $3.07
- 昨日收盘价
- $2.93
- 成交量
- 3.16万
- 市值
- $8134.85万
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-0.11
昨日价格区间
$2.82$3.09
52周价格区间
$0.01$0.78
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 生物技术
- 总部
- 500 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
- 国家
- AU
- 上市日期
- 2000-03-28
- 财年截止
- 六月
- 流通股数
- 2.17亿
- CIK
- 0001131343
Alterity Therapeutics Limited 在澳大利亚研究和开发用于治疗帕金森病及其他神经退行性疾病的治疗药物。公司总部位于澳大利亚墨尔本。
财务指标
营业收入
2026-06-30
--
2025-12-31
--
2025-06-30
$383.29万
2024-12-31
$160.59万
营业支出
2026-06-30
$1552.13万
2025-12-31
$1276.1万
2025-06-30
$1085.72万
2024-12-31
$902.84万
净利润
2026-06-30
-$1397.97万
2025-12-31
-$943.94万
2025-06-30
-$497.44万
2024-12-31
-$717.33万
净利润率
2026-06-30
--
2025-12-31
--
2025-06-30
-129.78%
2024-12-31
-446.67%
每股收益
2026-06-30
--
2025-12-31
--
2025-06-30
$0.00
2024-12-31
$0.00
息税折旧摊销前利润
2026-06-30
-$1552.13万
2025-12-31
-$1276.1万
2025-06-30
-$704.77万
2024-12-31
-$747.2万
有效税率
2026-06-30
5.19%
2025-12-31
22.18%
2025-06-30
-1.38%
2024-12-31
18.29%
| 项目 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| 营业收入 | -- | -- | $383.29万 | $160.59万 |
| 营业支出 | $1552.13万 | $1276.1万 | $1085.72万 | $902.84万 |
| 净利润 | -$1397.97万 | -$943.94万 | -$497.44万 | -$717.33万 |
| 净利润率 | -- | -- | -129.78% | -446.67% |
| 每股收益 | -- | -- | $0.00 | $0.00 |
| 息税折旧摊销前利润 | -$1552.13万 | -$1276.1万 | -$704.77万 | -$747.2万 |
| 有效税率 | 5.19% | 22.18% | -1.38% | 18.29% |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。